Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (351-360 of 535) with videos related to

Pageof 54
Sort By:
Biorxiv : the Preprint Server for Biology|September 8, 2021
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profilesPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2016
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated SubjectsYunda Huang, Guido Ferrari, Galit Alter, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Ebiomedicine|June 28, 2023
IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold minersLeela R L Davies, Malisa T Smith, Deniz Cizmeci, et al.
Nature Biomedical Engineering|September 19, 2020
Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19Maia Norman, Tal Gilboa, Alana F Ogata, et al.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
The Journal of Infectious Diseases|November 6, 2012
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)Dan H Barouch, Jinyan Liu, Lauren Peter, et al.
The Journal of Infectious Diseases|November 18, 2021
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed IndividualsAi-Ris Y Collier, Jingyou Yu, Katherine McMahan, et al.
Plos Computational Biology|April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence featuresCraig A Magaret, David C Benkeser, Brian D Williamson, et al.
Pageof 54

Showing results (351-360 of 535) with videos related to

Sort By:
Pageof 54
Biorxiv : the Preprint Server for Biology|September 8, 2021
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profilesPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2016
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated SubjectsYunda Huang, Guido Ferrari, Galit Alter, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Ebiomedicine|June 28, 2023
IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold minersLeela R L Davies, Malisa T Smith, Deniz Cizmeci, et al.
Nature Biomedical Engineering|September 19, 2020
Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19Maia Norman, Tal Gilboa, Alana F Ogata, et al.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
The Journal of Infectious Diseases|November 6, 2012
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)Dan H Barouch, Jinyan Liu, Lauren Peter, et al.
The Journal of Infectious Diseases|November 18, 2021
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed IndividualsAi-Ris Y Collier, Jingyou Yu, Katherine McMahan, et al.
Plos Computational Biology|April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence featuresCraig A Magaret, David C Benkeser, Brian D Williamson, et al.
Pageof 54